Effects of extrathoracic mechanical ventilation on pulmonary hypertension secondary to lung disease

go back to reference Haouat A, Naeije R, Weitzenblum E. Pulmonary hypertension in COPD. Eur Respir J. 2008;32:1371–85.CrossRef Haouat A, Naeije R, Weitzenblum E. Pulmonary hypertension in COPD. Eur Respir J. 2008;32:1371–85.CrossRef

go back to reference Galie N, Ghofrani HA, Torbicki A, Barst RJ, Rubin LJ, Badesch D, Fleming T, Parpia T, Burgess G, Branzi A, Grimminger F, Kurzyna M, Simonneau G, Sildenafil Use in Pulmonary Arterial Hypertension (SUPER) Study Group. Sildenafil citrate therapy for pulmonary arterial hypertension. N Engl J Med. 2005;353:2148–57.CrossRefPubMed Galie N, Ghofrani HA, Torbicki A, Barst RJ, Rubin LJ, Badesch D, Fleming T, Parpia T, Burgess G, Branzi A, Grimminger F, Kurzyna M, Simonneau G, Sildenafil Use in Pulmonary Arterial Hypertension (SUPER) Study Group. Sildenafil citrate therapy for pulmonary arterial hypertension. N Engl J Med. 2005;353:2148–57.CrossRefPubMed

go back to reference McLaughlin VV, Archer SL, Badesch DB, Barst RJ, Farber HW, Lindner JR, Mathier MA, McGoon MD, Park MH, Rosenson RS, Rubin LJ, Tapson VF, Varga J; American College of Cardiology Foundation Task Force on Expert Consensus Documents; American Heart Association; American College of Chest Physicians; American Thoracic Society, Inc; Pulmonary Hypertension Association. ACCF/AHA 2009 expert consensus document on pulmonary hypertension a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association developed in collaboration with the American College of Chest Physicians; American Thoracic Society, Inc.; and the Pulmonary Hypertension Association. J Am Coll Cardiol 2009; 53:1573–1619. McLaughlin VV, Archer SL, Badesch DB, Barst RJ, Farber HW, Lindner JR, Mathier MA, McGoon MD, Park MH, Rosenson RS, Rubin LJ, Tapson VF, Varga J; American College of Cardiology Foundation Task Force on Expert Consensus Documents; American Heart Association; American College of Chest Physicians; American Thoracic Society, Inc; Pulmonary Hypertension Association. ACCF/AHA 2009 expert consensus document on pulmonary hypertension a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents and the American Heart Association developed in collaboration with the American College of Chest Physicians; American Thoracic Society, Inc.; and the Pulmonary Hypertension Association. J Am Coll Cardiol 2009; 53:1573–1619.

go back to reference Stolz D, Rasch H, Linka A, Di Valentino M, Meyer A, Brutsche M, Tamm M. A randomised, controlled trial of bosentan in severe COPD. Eur Respir J. 2008;32:619–28.CrossRefPubMed Stolz D, Rasch H, Linka A, Di Valentino M, Meyer A, Brutsche M, Tamm M. A randomised, controlled trial of bosentan in severe COPD. Eur Respir J. 2008;32:619–28.CrossRefPubMed

go back to reference Ghofrani HA, Wiedemann R, Rose F, Schermuly RT, Olschewski H, Weissmann N, Gunther A, Walmrath D, Seeger W, Grimminger F. Sildenafil for treatment of lung fibrosis and pulmonary hypertension: a randomised controlled trial. Lancet. 2002;360:895–900.CrossRefPubMed Ghofrani HA, Wiedemann R, Rose F, Schermuly RT, Olschewski H, Weissmann N, Gunther A, Walmrath D, Seeger W, Grimminger F. Sildenafil for treatment of lung fibrosis and pulmonary hypertension: a randomised controlled trial. Lancet. 2002;360:895–900.CrossRefPubMed

go back to reference Gunther A, Enke B, Markart P, Hammerl P, Morr H, Behr J, Stahler G, Seeger W, Grimminger F, Leconte I, Roux S, Ghofrani HA. Safety and tolerability of bosentan in idiopathic pulmonary fibrosis: an open label study. Eur Respir J. 2007;29:713–9.CrossRefPubMed Gunther A, Enke B, Markart P, Hammerl P, Morr H, Behr J, Stahler G, Seeger W, Grimminger F, Leconte I, Roux S, Ghofrani HA. Safety and tolerability of bosentan in idiopathic pulmonary fibrosis: an open label study. Eur Respir J. 2007;29:713–9.CrossRefPubMed

go back to reference Rietema H, Holverda S, Bogaard HJ, Marcus JT, Smit HJ, Westerhof N, Postmus PE, Boonstra A, Vonk-Noordegraaf A. Sildenafil treatment in COPD does not affect stroke volume or exercise capacity. Eur Respir J. 2008;31:759–64.CrossRefPubMed Rietema H, Holverda S, Bogaard HJ, Marcus JT, Smit HJ, Westerhof N, Postmus PE, Boonstra A, Vonk-Noordegraaf A. Sildenafil treatment in COPD does not affect stroke volume or exercise capacity. Eur Respir J. 2008;31:759–64.CrossRefPubMed

go back to reference Task Force for Diagnosis and Treatment of Pulmonary Hypertension of European Society of Cardiology (ESC), European Respiratory Society (ERS); International Society of Heart and Lung Transplantation (ISHLT), Galie N, Hoeper MM, Humbert M, Torbicki A, Vachiery JL, Barbera JA, Beghetti M, Corris P, Gaine S, Gibbs JS, Gomez-Sanchez MA, Jondeau G, Klepetko W, Opitz C, Peacock A, Rubin L, Zellweger M, Simonneau G. Guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Respir J. 2009;34:1219–63.CrossRef Task Force for Diagnosis and Treatment of Pulmonary Hypertension of European Society of Cardiology (ESC), European Respiratory Society (ERS); International Society of Heart and Lung Transplantation (ISHLT), Galie N, Hoeper MM, Humbert M, Torbicki A, Vachiery JL, Barbera JA, Beghetti M, Corris P, Gaine S, Gibbs JS, Gomez-Sanchez MA, Jondeau G, Klepetko W, Opitz C, Peacock A, Rubin L, Zellweger M, Simonneau G. Guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Respir J. 2009;34:1219–63.CrossRef

go back to reference Oswald-Mammosser M, Weitzenblum E, Quoix E, Moser G, Chaouat A, Charpentier C, Kessler R. Prognostic factors in COPD patients receiving long-term oxygen therapy. Importance of pulmonary artery pressure. Chest. 1995;107:1193–8.CrossRefPubMed Oswald-Mammosser M, Weitzenblum E, Quoix E, Moser G, Chaouat A, Charpentier C, Kessler R. Prognostic factors in COPD patients receiving long-term oxygen therapy. Importance of pulmonary artery pressure. Chest. 1995;107:1193–8.CrossRefPubMed

go back to reference Corrado A, Gorini M, Melej R, Baglioni S, Mollica C, Villella G, Consigli GF, Dottorini M, Bigioni D, Toschi M, Eslami A. Iron lung versus mask ventilation in acute exacerbation of COPD: a randomised crossover study. Intensive Care Med. 2009;35:648–55.CrossRefPubMed Corrado A, Gorini M, Melej R, Baglioni S, Mollica C, Villella G, Consigli GF, Dottorini M, Bigioni D, Toschi M, Eslami A. Iron lung versus mask ventilation in acute exacerbation of COPD: a randomised crossover study. Intensive Care Med. 2009;35:648–55.CrossRefPubMed

go back to reference Shekerdemian LS, Bush A, Shore DF, Lincoln C, Redington AN. Cardiopulmonary interactions after Fontan operations: augmentation of cardiac output using negative pressure ventilation. Circulation. 1997;96:3934–42.CrossRefPubMed Shekerdemian LS, Bush A, Shore DF, Lincoln C, Redington AN. Cardiopulmonary interactions after Fontan operations: augmentation of cardiac output using negative pressure ventilation. Circulation. 1997;96:3934–42.CrossRefPubMed

go back to reference Sills JH, Cvetnic WG, Pietz J. Continuous negative pressure in the treatment of infants with pulmonary hypertension and respiratory failure. J Perinatol. 1989;9:43–8.PubMed Sills JH, Cvetnic WG, Pietz J. Continuous negative pressure in the treatment of infants with pulmonary hypertension and respiratory failure. J Perinatol. 1989;9:43–8.PubMed

go back to reference Sato Y, Kuryu K, Shikama Y, Kasahara K, Nakajima H, Sato T, Kotani T. A case of improvement in acute exacerbation of chronic respiratory failure after thoracoplasty by extrathoracic mechanical ventilation (in Japanese with English abstract). Kokyu to Junkan (Respir Circ). 2008;56:961–5. Sato Y, Kuryu K, Shikama Y, Kasahara K, Nakajima H, Sato T, Kotani T. A case of improvement in acute exacerbation of chronic respiratory failure after thoracoplasty by extrathoracic mechanical ventilation (in Japanese with English abstract). Kokyu to Junkan (Respir Circ). 2008;56:961–5.

go back to reference Schonhofer B, Barchfeld T, Wenzel M, Kohler D. Long term effects of non-invasive mechanical ventilation on pulmonary haemodynamics in patients with chronic respiratory failure. Thorax. 2001;56:524–8.CrossRefPubMedPubMedCentral Schonhofer B, Barchfeld T, Wenzel M, Kohler D. Long term effects of non-invasive mechanical ventilation on pulmonary haemodynamics in patients with chronic respiratory failure. Thorax. 2001;56:524–8.CrossRefPubMedPubMedCentral

go back to reference Glerant JC, Jounieaux V, Parreira VF, Dury M, Aubert G, Rodenstein DO. Effects of intermittent negative pressure ventilation on effective ventilation in normal awake subjects. Chest. 2002;122:99–107.CrossRefPubMed Glerant JC, Jounieaux V, Parreira VF, Dury M, Aubert G, Rodenstein DO. Effects of intermittent negative pressure ventilation on effective ventilation in normal awake subjects. Chest. 2002;122:99–107.CrossRefPubMed

go back to reference Hirasawa J, Arizono S, Taniguchi H, Ogawa T, Watanabe F, Hasegaw R. Relationship between intermittent negative pressure level and tidal volume during biphasic cuirass ventilation in normal subjects [in Japanese]. Nihon Kokyuki Gakkai Zasshi. 2011;49:990–2.PubMed Hirasawa J, Arizono S, Taniguchi H, Ogawa T, Watanabe F, Hasegaw R. Relationship between intermittent negative pressure level and tidal volume during biphasic cuirass ventilation in normal subjects [in Japanese]. Nihon Kokyuki Gakkai Zasshi. 2011;49:990–2.PubMed

go back to reference Kinnear W, Petch M, Taylor G, Shneerson J. Assisted ventilation using cuirass respirators. Eur Respir J. 1988;1:198–203.PubMed Kinnear W, Petch M, Taylor G, Shneerson J. Assisted ventilation using cuirass respirators. Eur Respir J. 1988;1:198–203.PubMed

go back to reference Gigliotti F, Spinelli A, Duranti R, Gorini M, Goti P, Scano G. Four-week negative pressure ventilation improves respiratory function in severe hypercapnic COPD patients. Chest. 1994;105:87–94.CrossRefPubMed Gigliotti F, Spinelli A, Duranti R, Gorini M, Goti P, Scano G. Four-week negative pressure ventilation improves respiratory function in severe hypercapnic COPD patients. Chest. 1994;105:87–94.CrossRefPubMed

go back to reference Corrado A, Gorini M, Villella G, De Paola E. Negative pressure ventilation in the treatment of acute respiratory failure: an old noninvasive technique reconsidered. Eur Respir J. 1996;9:1531–44.CrossRefPubMed Corrado A, Gorini M, Villella G, De Paola E. Negative pressure ventilation in the treatment of acute respiratory failure: an old noninvasive technique reconsidered. Eur Respir J. 1996;9:1531–44.CrossRefPubMed

go back to reference Scharf SM, Iqbal M, Keller C, Criner G, Lee S, Fessler HE, National Emphysema Treatment Trial (NETT) Group. Hemodynamic characterization of patients with severe emphysema. Am J Respir Crit Care Med. 2002;166:314–22.CrossRefPubMed Scharf SM, Iqbal M, Keller C, Criner G, Lee S, Fessler HE, National Emphysema Treatment Trial (NETT) Group. Hemodynamic characterization of patients with severe emphysema. Am J Respir Crit Care Med. 2002;166:314–22.CrossRefPubMed

go back to reference Butler J, Schrijen F, Henriquez A, Polu JM, Albert RK. Cause of the raised wedge pressure on exercise in chronic obstructive pulmonary disease. Am Rev Respir Dis. 1988;138:350–4.CrossRefPubMed Butler J, Schrijen F, Henriquez A,  Polu JM, Albert RK. Cause of the raised wedge pressure on exercise in chronic obstructive pulmonary disease. Am Rev Respir Dis. 1988;138:350–4.CrossRefPubMed

go back to reference Chabot F, Schrijen F, Poincelot F, Polu JM, Albert RK. Interpretation of high wedge pressure on exercise in patients with chronic obstructive pulmonary disease. Cardiology. 2001;95:139–45.CrossRefPubMed Chabot F, Schrijen F, Poincelot F, Polu JM, Albert RK. Interpretation of high wedge pressure on exercise in patients with chronic obstructive pulmonary disease. Cardiology. 2001;95:139–45.CrossRefPubMed

go back to reference Grasso F, Engelberts D, Helm E, Frndova H, Jarvis S, Talakoub O, McKerlie C, Babyn P, Post M, Kavanagh BP. Negative-pressure ventilation: better oxygenation and less lung injury. Am J Respir Crit Care Med. 2008;177:412–8.CrossRefPubMed Grasso F, Engelberts D, Helm E, Frndova H, Jarvis S, Talakoub O, McKerlie C, Babyn P, Post M, Kavanagh BP. Negative-pressure ventilation: better oxygenation and less lung injury. Am J Respir Crit Care Med. 2008;177:412–8.CrossRefPubMed

go back to reference Takeda S, Nakanishi K, Takano T, Ishikawa G, Ogawa R. Effect of external high-frequency oscillation on severe cardiogenic pulmonary edema. J Anesth. 1997;11:83–7.CrossRefPubMed Takeda S, Nakanishi K, Takano T, Ishikawa G, Ogawa R. Effect of external high-frequency oscillation on severe cardiogenic pulmonary edema. J Anesth. 1997;11:83–7.CrossRefPubMed

go back to reference Sideno B, Vaage J. Ventilation by external high-frequency oscillations improves cardiac function after coronary artery bypass grafting. Eur J Cardiothorac Surg. 1997;11:248–57.CrossRefPubMed Sideno B, Vaage J. Ventilation by external high-frequency oscillations improves cardiac function after coronary artery bypass grafting. Eur J Cardiothorac Surg. 1997;11:248–57.CrossRefPubMed

go back to reference Mauritz GJ, Rizopoulos D, Groepenhoff H, Tiede H, Felix J, Eilers P, Bosboom J, Postmus PE, Westerhof N, Vonk-Noordegraaf A. Usefulness of serial N-terminal Pro-B-type natriuretic peptide measurements for determining prognosis in patients with pulmonary arterial hypertension. Am J Cardiol. 2011;108:1645–50.CrossRefPubMed Mauritz GJ, Rizopoulos D, Groepenhoff H, Tiede H, Felix J, Eilers P, Bosboom J, Postmus PE, Westerhof N, Vonk-Noordegraaf A. Usefulness of serial N-terminal Pro-B-type natriuretic peptide measurements for determining prognosis in patients with pulmonary arterial hypertension. Am J Cardiol. 2011;108:1645–50.CrossRefPubMed

go back to reference Fijalkowska A, Kurzyna M, Torbicki Szewczyk G, Florczyk M, Pruszczyk P, Szturmowicz MA. Serum N-terminal brain natriuretic peptide as a prognostic parameter in patients with pulmonary hypertension. Chest. 2006;129:1313–21.CrossRefPubMed Fijalkowska A, Kurzyna M, Torbicki Szewczyk G, Florczyk M, Pruszczyk P, Szturmowicz MA. Serum N-terminal brain natriuretic peptide as a prognostic parameter in patients with pulmonary hypertension. Chest. 2006;129:1313–21.CrossRefPubMed

go back to reference Vonk Noordegraaf A, Westerhof N. Right ventricular ejection fraction and NT-proBNP are both indicators of wall stress in pulmonary hypertension. Eur Respir J. 2007;29:622–33.CrossRefPubMed Vonk Noordegraaf A, Westerhof N. Right ventricular ejection fraction and NT-proBNP are both indicators of wall stress in pulmonary hypertension. Eur Respir J. 2007;29:622–33.CrossRefPubMed